SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice. - Wikidata - awgldk - TriplyDB

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.

http://www.wikidata.org/entity/Q33659934

about

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma Albumin-based drug delivery: harnessing nature to cure disease Perspectives in the treatment of pancreatic adenocarcinoma Nanoparticle-mediated drug delivery for treating melanoma Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies Desmoplasia and chemoresistance in pancreatic cancer Update on the management of pancreatic cancer: surgery is not enough A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.Stromal reengineering to treat pancreas cancer Fibroblast heterogeneity in the cancer wound.Unraveling the mysteries of serum albumin-more than just a serum protein.Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.Organoid models of human and mouse ductal pancreatic cancer Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells Circulating miRNAs in cancer: from detection to therapy.Pancreatic Cancer: a Challenge to Cure Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.Metastatic progression is associated with dynamic changes in the local microenvironment.Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer.Uptake carriers and oncology drug safety.Role of pancreatic stellate cells in chemoresistance in pancreatic cancer.Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer.The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.Stromal biology and therapy in pancreatic cancer: a changing paradigm.Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.Application of albumin-based nanoparticles in the management of cancer.S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

P2860

Q24627664-696776E1-C216-4DCD-B72E-D7C0862B94FE Q26765789-351D4A09-1C9C-4437-B53A-E7FBCB042EC4 Q26797248-FB826813-BD77-4A24-BE91-499176CBFB4B Q26798379-FEFA9EE3-40C7-4D69-B595-E46518645630 Q26799714-729C753E-4574-4C81-94DC-BC425D53128D Q26864497-540CA9A6-7AB2-457E-AAEC-E1C21668CB58 Q28087060-0B239109-B082-4921-A750-E329E27BAE4D Q30669159-8AA2D4AB-FD82-4DD6-BC42-146CFDA61657 Q33361738-5E1849A2-04AB-4203-B92E-D4A62FF4EFB1 Q33435134-72F01355-BD19-43F0-A55E-67F18EFE76A0 Q33681427-C84FD679-BC4A-4731-A82D-114D403918AD Q33827708-653D6C85-B48C-4406-AD21-A321F2433E9B Q33964324-DCC6C4F8-AD33-432F-A8F4-E5798B24ACD9 Q34030577-EA531C9C-8E23-459D-8D28-C6C9C34ACC12 Q34067863-D360C3B0-9C23-4EE3-9F95-5A0D5968D062 Q34431614-8A314172-ACB3-4E28-89DC-882729940CB4 Q34456438-DA751F52-23D0-4A76-A4DF-F24E05B53215 Q34502783-11283630-A12B-4CEF-B706-2224E38A212F Q34728385-7CE3D13F-4353-4B13-99CA-F558CB43BDA0 Q36400081-AB7E7830-1225-466C-AB67-4773B829B855 Q36578825-67654EEE-4AD2-49C6-AC39-150ADD38F2D1 Q36848514-DBAEB97F-2ED5-4E4C-B035-B889B8F600C4 Q36917864-E52FEDDB-8924-4730-A957-A50744BEEBD6 Q37029731-15412A83-92D8-4F97-A7AC-47AA67378095 Q37228217-D72201B1-E4B9-4ED4-BF35-7F2D7BDEECDD Q37264732-4C7949EE-54B3-4C04-9013-3340DC701461 Q37361227-62CB730D-940E-49D9-B9A2-CBDAA2802020 Q37398885-1E0BE059-938B-4D18-B0D9-67B1942C2948 Q37577579-C4A7FDF0-E63A-4000-824E-631DC8E83D6E Q37663396-33DB4209-3105-4D7A-974C-58FCF1D14D1E Q37705462-CC86D9C5-027B-446E-AA8E-B8AF90356F84 Q38165930-445134A7-C101-42D7-BDD7-EC332003B240 Q38310416-A0E530B2-92E1-4C16-90D1-F3F515A5C51D Q38494338-6A2F05B9-29B0-4EB3-A305-3034880BD32A Q38577297-6BFBC26E-C9BC-49AC-8854-0476F57EDA7E Q38649063-CDE081FC-B630-403E-ABC3-8423742826DC Q38776511-5388CD3E-5059-4496-9DA0-385F91E037B2 Q38878437-3BA8A3F0-D71F-44C2-868E-D4965EB3574C Q38985417-7014E785-408E-4FC0-BC22-5A111CFFFC57 Q39001980-0AF7F672-BC05-4A30-9086-53A68D7343B3

P2860

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.

http://www.wikidata.org/entity/Q33659934

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

SPARC independent drug deliver ...... n genetically engineered mice.

@ast

SPARC independent drug deliver ...... n genetically engineered mice.

@en

type

label

SPARC independent drug deliver ...... n genetically engineered mice.

@ast

SPARC independent drug deliver ...... n genetically engineered mice.

@en

prefLabel

SPARC independent drug deliver ...... n genetically engineered mice.

@ast

SPARC independent drug deliver ...... n genetically engineered mice.

@en

P1433

Q33659934-3702CC61-6D81-4BC2-990B-81B66C36F7FB

P1476

Q33659934-83A42DDD-22C3-41BD-8BF9-D97BFAD9B0EA

P2093

Q33659934-15519DF8-1631-43FB-A7AC-F42D184B0F99

Q33659934-30F83F8A-89C0-4FB4-A36A-AEDC6D34ACE0

Q33659934-3A292F0C-3761-431B-A961-FC8346FEBE9C

Q33659934-47ED696B-BD7A-4FA5-931E-5F8C1528B34D

Q33659934-6F261D12-1A79-4169-8723-0C550758A32C

Q33659934-B54F01CE-244D-4F66-B112-A3E0439467F1

Q33659934-D9ADE88B-23A8-421F-B765-6D28FAD54FD8

Q33659934-EEECF6E6-C851-47E8-9F0D-531A2A5A5AA4

P2860

Q33659934-05FFFA95-CDB0-4228-B39C-5C090CFC4D7E

Q33659934-1090A72B-68A3-469B-A612-EA31A133C9A5

Q33659934-154A0578-DA4A-4237-947E-1FFA5EE06BE9

Q33659934-21B0B0C3-E9E6-4EB7-8A0D-86A30C3A4BDB

Q33659934-263A1163-041F-43E9-AA5E-72F47A1296D4

Q33659934-3416DBEB-DE91-4095-8936-FE43D19A4A8E

Q33659934-35AB5512-CDBE-4D86-B019-382BC45D4681

Q33659934-39E082F0-BE82-4576-8228-C6F1F9EDABB0

Q33659934-3C4A3216-51B2-4457-BCBD-AB07D8B02A64

Q33659934-3CFAF165-4F80-4A48-974A-1BE39511A8C3

P304

Q33659934-6A5D2CF9-A8CA-4512-A539-701D13E39BD3

P31

Q33659934-E918E3A5-AFED-48D9-95DA-152B1D5FDF60

P356

Q33659934-EC9DB783-D5DC-4935-A24F-765B762E792F

P407

Q33659934-16CECDDE-8192-4757-A8C0-7C2C8B474241

P433

Q33659934-966DA8C2-021E-4FFB-AB0C-0EDFFA61C965

P478

Q33659934-7C5E7357-D369-4E1B-8B40-FFD37825339E

P50

Q33659934-00272FE6-D37C-45C5-941F-6CDE9A08CCBC

P577

Q33659934-D0B10F68-E7DC-4AD2-93DA-25E0BE902301

P5875

Q33659934-15B95EC4-A3C2-46F6-85BF-EF3931ABFA90

P698

Q33659934-A55E598D-8EE9-4268-BE18-0AEA22A7E118

P921

Q33659934-97C0A933-76B8-4A79-AF6E-C0B2B06835C8

P932

Q33659934-D4AE2605-2CC2-470D-B1BC-96FE20E741DA

P356

GUTJNL-2013-305559

P1433

P1476

SPARC independent drug deliver ...... n genetically engineered mice.

@en

P2093

Albrecht Neesse

http://www.w3.org/2001/XMLSchema#string

Derek S Chan

http://www.w3.org/2001/XMLSchema#string

Duncan I Jodrell

http://www.w3.org/2001/XMLSchema#string

Frances M Richards

http://www.w3.org/2001/XMLSchema#string

Kristopher K Frese

http://www.w3.org/2001/XMLSchema#string

Tashinga E Bapiro

http://www.w3.org/2001/XMLSchema#string

Volker Ellenrieder

http://www.w3.org/2001/XMLSchema#string

William J Howat

http://www.w3.org/2001/XMLSchema#string

P2860

Human platelets contain and secrete osteonectin, a major protein of mineralized bone

Cancer statistics, 2013

Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

EMT and dissemination precede pancreatic tumor formation

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

P304

974-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2013-305559

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257073809

http://www.w3.org/2001/XMLSchema#string

P698

24067278

http://www.w3.org/2001/XMLSchema#string

P921

P932

4033275

http://www.w3.org/2001/XMLSchema#string